arrow
M

Mahmoud Zureik

inserm french national institute of health and medical research
H指数:57
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world efficacy and safety of trastuzumab deruxtecan versus trastuzumab emtansine and tucatinib as second-line and third-line treatments for HER2-positive metastatic breast cancer: two target trial emulation studies

曲妥珠单抗德鲁替康与曲妥珠单抗梅坦新和图卡替尼作为HER2阳性转移性乳腺癌二线及三线治疗的实际疗效与安全性:两项目标试验模拟研究

2025-09-050
PREAI